InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-0.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Castelein Caley, Director. Director active across 4 companies, notably ViewRay, Inc.. Aggregated, 18 filings have been logged. Split: 4 buys · 1 sell. Total volume traded: €6.7m. Activity tracked since 14 June 2021. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
515,997 sharesCommon StockSEC:0001355758-25-000006:0
431,939 sharesCommon StockSEC:0001355758-25-000006:1
1,666,000 shares@ US$2.4030.0% of flowCommon StockSEC:0001415889-25-006742:0
4,200 shares@ US$12.07100.0% of flowCommon StockSEC:0001209191-23-053791:0
Ideal exit: 21 Jul 2024 (T+270)
496,519 sharesCommon StockSEC:0001209191-23-053389:0
158,397 shares@ US$0.0680.9% of flowCommon StockSEC:0001628280-23-025331:0
16,590 shares@ US$4.406.4% of flowCommon StockSEC:0001628280-23-000250:0
240,000 shares@ US$12.5024.5% of flowCommon StockSEC:0001209191-22-051391:0
54,511 shares0Common StockSEC:0001628280-22-017230:0
350,000 shares@ US$2.570486.9% of flowCommon StockSEC:0001628280-22-014015:0
Ideal exit: 4 Feb 2023 (T+270)
12,521 shares@ US$5.836.1% of flowCommon StockSEC:0001628280-22-000344
12,521 shares@ US$5.836.5% of flowCommon StockSEC:0001628280-22-000344:0
259,998 shares@ US$13.07722.7% of flowCommon StockSEC:0000899243-21-034553
Ideal exit: 23 May 2022 (T+270)
259,998 shares@ US$13.07750.0% of flowCommon StockSEC:0000899243-21-034553:0
Ideal exit: 23 May 2022 (T+270)
7,811 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027286
7,811 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027286:0
19,759 shares0Common StockSEC:0001209191-21-040911
19,759 shares0Common StockSEC:0001209191-21-040911:0
18 of 18 declarations
About Castelein Caley
Caley Castelein is a Director at ViewRay, Inc., Aerpio Pharmaceuticals, Inc., and Aadi Bioscience, Inc. In this role, she participates in the governance of all three companies and in strategic decision-making. Her experience in the biotechnology sector is valuable for these companies.
